Inpharma Weekly

, Volume 1666, Issue 1, pp 7–8 | Cite as

Cancer news from ISPOR

News item
  • 4 Downloads

Keywords

Bevacizumab Docetaxel Imatinib Trastuzumab Sorafenib 

Copyright information

© Adis International Ltd 2008

Personalised recommendations